BUY Larsen & Toubro Ltd. — Manas Jaiswal
byManas JaiswalHorizon: BTST13 Aug 2026, 3:14 pm ISTvia CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · adjacent horizon·14 Aug · today
Larsen & Toubro Limited has secured new orders/contracts.
NSE · Bagging/Receiving of orders/contracts·13 Aug · yesterday
Larsen & Toubro has secured a mega order to build India's largest NVIDIA B300 AI Factory in partnership with Together AI.
BSE · Company Update·13 Aug · yesterday
Mcap of four of top-10 most valued firms jumps Rs 1.43 lakh cr; State Bank biggest winner
NewsEt-Markets·9 Aug · 5d ago
Larsen & Toubro (L&T) Energy Hydrocarbon Offshore has secured a batch of orders from ONGC for the Pipeline Replacement Project (PRP-X) and Well Head Platforms Project. The orders involve EPCIC of mult
NSE · Bagging/Receiving of orders/contracts·7 Aug · 1w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Larsen & Toubro
- BUY — Rachna Vaidya13 Oct 2026 · Next day · target ₹3,720 · SL hit
- BUY — Rakesh Bansal1 Oct 2026 · ~2 weeks · target ₹3,900 · SL hit
- BUY — Prakash Gaba18 Sept 2026 · ~2 weeks · target ₹3,950 · SL hit
- BUY — Swati Hotkar, Nirmal Bang Securities15 Sept 2026 · ~3 months · target ₹4,200 · Active
- BUY — Sachin Gupta9 Sept 2026 · Same day · target ₹4,100 · SL hit
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

